Preliminary investigation of human exhaled breath for tuberculosis diagnosis by multidimensional gas chromatography - Time of flight mass spectrometry and machine learning.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published Date:

Abstract

Tuberculosis (TB) remains a global public health malady that claims almost 1.8 million lives annually. Diagnosis of TB represents perhaps one of the most challenging aspects of tuberculosis control. Gold standards for diagnosis of active TB (culture and nucleic acid amplification) are sputum-dependent, however, in up to a third of TB cases, an adequate biological sputum sample is not readily available. The analysis of exhaled breath, as an alternative to sputum-dependent tests, has the potential to provide a simple, fast, and non-invasive, and ready-available diagnostic service that could positively change TB detection. Human breath has been evaluated in the setting of active tuberculosis using thermal desorption-comprehensive two-dimensional gas chromatography-time of flight mass spectrometry methodology. From the entire spectrum of volatile metabolites in breath, three random forest machine learning models were applied leading to the generation of a panel of 46 breath features. The twenty-two common features within each random forest model used were selected as a set that could distinguish subjects with confirmed pulmonary M. tuberculosis infection and people with other pathologies than TB.

Authors

  • Marco Beccaria
    Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.
  • Theodore R Mellors
    Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.
  • Jacky S Petion
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Christiaan A Rees
    Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
  • Mavra Nasir
    Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
  • Hannah K Systrom
    Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
  • Jean W Sairistil
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Marc-Antoine Jean-Juste
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Vanessa Rivera
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Kerline Lavoile
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Patrice Severe
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Jean W Pape
    Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti; Department of Medicine of Weill Cornell Medical College, New York, NY, USA.
  • Peter F Wright
    Division of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
  • Jane E Hill
    Thayer School of Engineering, Dartmouth College, Hanover, NH, USA; Geisel School of Medicine, Dartmouth College, Hanover, NH, USA. Electronic address: jane.e.hill@dartmouth.edu.